Project Adverse Events Sample Clauses

Project Adverse Events. DOE shall have received a certification from the Borrower that no PAE has occurred for which at least 90% of the Ownership Interests in the Project have not been voted in favor of continuing the construction, completion, testing, startup and pre-operational turnover of the Project.
Sample 1Sample 2
AutoNDA by SimpleDocs
Project Adverse Events. DOE shall have received a certification from the Borrower that as of the Advance Notice Date and the Advance Date either (a) no PAE has occurred or (b) a PAE has occurred and (i) at least 90% of the Ownership Interests in the Project have been voted in favor of continuing the construction, completion, testing, startup and pre-operational turnover of the Project, (ii) no Deferral Period has occurred and is continuing, and (iii) the Borrower has provided DOE with the information required by clause (A) of the first sentence of Section 6.15 (Project Adverse Events) in connection with such PAE. In addition, if the Borrower determines that a material change to the Construction Budget or Summary Project Milestone Schedule — Regulatory Based has occurred, or is reasonably expected to occur, as a result of such PAE, the Borrower shall have delivered to DOE an updated Advance Schedule, Project Milestone Schedule, Summary Project Milestone Schedule — Working Plan, Summary Project Milestone Schedule — Regulatory Based and Construction Budget. Any change in the Summary Project Milestone Schedule — Regulatory Based that would constitute a PAE pursuant to Section 2.1(a)(iv) of the Owners’ Continuation Agreement and Amendment shall be deemed to be a material change to the Summary Project Milestone Schedule — Regulatory Based.
Sample 1
Project Adverse Events. If (i) a PAE has occurred and at least 90% of the Ownership Interests in the Project have been voted in favor of continuing construction, completion, testing, startup and pre-operational turnover of the Project, and (ii) if the Borrower determines that a material change to the Construction Budget or Summary Project Milestone Schedule — Regulatory Based has occurred, or is reasonably expected to occur, as a result of such PAE, the Borrower shall (A) promptly inform DOE of how the Borrower expects to fund any Overrun Project Costs and (B) when finalized, provide DOE with an updated Construction Budget, Summary Project Milestone Schedule — Working Plan, Summary Project Milestone Schedule — Regulatory Based and Project Milestone Schedule. The obligations of the Borrower in clause (A) may be satisfied by identifying general sources of funding (such as capital or bank finance markets or other sources of funding) the Borrower reasonably expects to be available to the Borrower, it being understood and agreed that the specific sources of funding that may be used by the Borrower in the future will be dependent on market conditions and other factors existing at the time such funding is obtained. Any change in the Summary Project Milestone Schedule — Regulatory Based that would constitute a PAE pursuant to Section 2.1(a)(iv) of the Owners’ Continuation Agreement and Amendment shall be deemed to be a material change to the Summary Project Milestone Schedule — Regulatory Based.
Sample 1

Related to Project Adverse Events

  • No Adverse Events Between the date hereof and the Closing Date, neither the business, assets or condition, financial or otherwise, of the Company taken as a whole shall have been materially adversely affected in any manner.

  • Adverse Events Subsequent to the date hereof, there shall not have occurred any of the following: (i) a suspension or material limitation in trading in securities generally on the New York Stock Exchange, the NASDAQ National Market or the NASDAQ Global Market, (ii) a general moratorium on commercial banking activities in the People’s Republic of China or New York, (iii) the outbreak or escalation of hostilities involving the United States or the People’s Republic of China or the declaration by the United States or the People’s Republic of China of a national emergency or war if the effect of any such event specified in this clause (iii) in your reasonable judgment makes it impracticable or inadvisable to proceed with the public offering or the delivery of the Shares on the terms and in the manner contemplated in the Prospectus, or (iv) such a material adverse change in general economic, political, financial or international conditions affecting financial markets in the United States or the People’s Republic of China having a material adverse impact on trading prices of securities in general, as, in your reasonable judgment, makes it impracticable or inadvisable to proceed with the public offering of the Shares or the delivery of the Shares on the terms and in the manner contemplated in the Prospectus.

  • No Material Adverse Event Since the respective dates as of which information is disclosed in the Registration Statement, the Prospectus and the Incorporated Documents, except as otherwise stated therein, there shall not have been (i) any change or decrease in previously reported results specified in the letter or letters referred to in paragraph (d) of this Section 6 or (ii) any change, or any development involving a prospective change, in or affecting the condition (financial or otherwise), earnings, business or properties of the Company and its subsidiaries taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Registration Statement, the Prospectus and the Incorporated Documents (exclusive of any amendment or supplement thereto) the effect of which, in any case referred to in clause (i) or (ii) above, is, in the sole judgment of the Manager, so material and adverse as to make it impractical or inadvisable to proceed with the offering or delivery of the Shares as contemplated by the Registration Statement (exclusive of any amendment thereof), the Incorporated Documents and the Prospectus (exclusive of any amendment or supplement thereto).

  • Adverse Event Reporting Both Parties acknowledge the obligation to comply with the Protocol and / or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical Trial. Both Parties agree to fulfil and ensure that their Agents fulfil regulatory requirements with respect to the reporting of adverse events.

  • Notice of Suits, Adverse Events Furnish Agent with prompt notice of (i) any lapse or other termination of any Consent issued to any Borrower by any Governmental Body or any other Person that is material to the operation of any Borrower's business, (ii) any refusal by any Governmental Body or any other Person to renew or extend any such Consent; and (iii) copies of any periodic or special reports filed by any Borrower with any Governmental Body or Person, if such reports indicate any material change in the business, operations, affairs or condition of any Borrower, or if copies thereof are requested by Lender, and (iv) copies of any material notices and other communications from any Governmental Body or Person which specifically relate to any Borrower.

  • Absence of Material Adverse Changes No material adverse change in the business, assets, financial condition, or prospects of the Company shall have occurred, no substantial part of the assets of the Company not substantially covered by insurance shall have been destroyed due to fire or other casualty, and no event shall have occurred which has had or will have a material adverse effect on the business, assets, financial condition or prospects of the Company.

  • Notice of Material Adverse Change Firm agrees to notify Citizens in writing of any “Material Adverse Change” to Firm within ten (10) days of said change. A “Material Adverse Change” means: (i) a change in the business operations or financial condition of Firm which negatively impacts its capacity to meet its professional or financial obligations;

  • No Material Adverse Changes There shall not have occurred any material adverse change in the condition (financial or otherwise), properties, assets (including intangible assets), liabilities, business, operations, results of operations or prospects of Acquiror and its subsidiaries, taken as a whole.

  • Absence of Material Adverse Change On the Closing Date, no circumstance shall exist that constitutes a REIT II Material Adverse Effect.

  • Company Material Adverse Effect Since the date of this Agreement, there shall not have been any Company Material Adverse Effect or any event, change, or effect that would, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!